Personality disorder and population mental health
Shae E Quirk, Lana J Williams, Andrew M Chanen, Michael Berk
LANCET PSYCHIATRY | ELSEVIER SCI LTD | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC) of Australia
Awarded by NHMRC Career Development Fellowship
Awarded by NHMRC Senior Principal Research Fellowship
SEQ is supported by a National Health and Medical Research Council (NHMRC) of Australia Postgraduate Scholarship (GNT1076347). LJW has received Grant/Research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University, and is supported by a NHMRC Career Development Fellowship (GNT1064272). AMC has received research funding from the NHMRC, Australian Research Council, Colonial Foundation, The University of Melbourne, and the New South Wales Department of Health. MB has received Grant/Research Support from the National Institute of Health (USA), Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, Medical Benefits Fund, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Organon, Novartis, Mayne Pharma, Servier and AstraZeneca. He has been a paid consultant for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth and is supported by a NHMRC Senior Principal Research Fellowship (GNT1059660).